0001437749-26-003997
SEC filingAstrotech Corporation reported a challenging second fiscal quarter ended December 31, 2025, characterized by minimal revenue generation and significant operational losses. Total revenue for the period was $148K, resulting in a gross profit of only $8K. The company faced substantial operating expenses totaling $3.9M, driven primarily by Selling, General and Administrative costs of $2.1M and Research and Development expenditures of $1.8M. Consequently, Astrotech reported a net loss of $3.9M for the quarter, translating to a net loss per common share of $2.00. From a liquidity perspective, the company maintains a solid position with total current assets of $14.3M, including $3.1M in cash and cash equivalents and $7.0M in short-term investments, against total current liabilities of $1.9M. Cash flow from operations showed a usage of $7.5M, which was offset by $7.5M provided by investing activities, primarily from short-term investment proceeds. The company continues to operate at a loss while funding R&D initiatives.
For the second fiscal quarter ended December 31, 2025, Astrotech Corporation reported total revenue of $148K with a cost of revenue of $140K, yielding a gross profit of $8K. The company incurred significant operating expenses totaling $3.9M, comprised of $2.1M in Selling, General and Administrative expenses and $1.8M in Research and Development. This resulted in a loss from operations of $3.9M. After accounting for $26K in other expenses, the net loss for the period was $3.9M. The basic and diluted net loss per common share was $2.00 based on 1.7M weighted average shares outstanding. The total comprehensive loss was slightly reduced to $3.8M due to a $168K net unrealized gain on available-for-sale securities.
Revenue for the quarter was minimal at $148K, barely exceeding the cost of revenue of $140K. The filing does not provide a breakdown of revenue by segment, geography, or product line. The low revenue generation highlights the company's current stage of operations, likely focusing on the development of its proprietary technologies. Without specific segment data disclosed in the XBRL or document text, the analysis is limited to the top-line figure. The gross margin was approximately 5.4%, indicating limited profitability at the revenue level before accounting for substantial operating overhead.
Astrotech's profitability metrics reflect an early-stage or development-focused company. The gross margin for the quarter was approximately 5.4%. However, operating margins were deeply negative at -2635.1%, driven by operating expenses ($3.9M) that vastly exceeded revenue ($148K). The primary cost drivers were Research and Development ($1.8M) and Selling, General and Administrative expenses ($2.1M). The net profit margin mirrored the operating margin, with a net loss of $3.9M. The company did not record any income tax expense for the period.
The balance sheet shows total assets of $19.7M against total liabilities of $4.2M, resulting in stockholders’ equity of $15.5M. Liquidity appears adequate in the short term, with total current assets of $14.3M (including $3.1M cash and $7.0M short-term investments) covering current liabilities of $1.9M. However, the cash flow statement reveals significant operational cash burn, with net cash used in operating activities totaling $7.5M. This was fully offset by net cash provided by investing activities of $7.5M, derived from short-term investment proceeds. Financing activities used $54K. The company holds an accumulated deficit of $258.3M.
The provided document text and XBRL data do not contain specific forward-looking statements, management guidance, or strategic priorities regarding future periods. The company continues to invest heavily in R&D ($1.8M for the quarter), suggesting an ongoing focus on product development. Investors should monitor the rate of cash burn relative to the company's liquid asset base of approximately $10.1M in cash and short-term investments. No specific risk factors or guidance figures were disclosed in the provided data sections.